Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma

M. Lopez, L. Di Lauro, P. Papaldo, F. Ganzina, N. Di Pietro, B. Lazzaro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)911-912
Number of pages2
JournalCancer Treatment Reports
Issue number7
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this